# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012065
Filing Date
2022-08-04
Accepted
2022-08-04 07:47:51
Documents
86
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tmb-20220630x10q.htm iXBRL | 10-Q | 2162794
2 | EX-31.1 | tmb-20220630xex31d1.htm | EX-31.1 | 10599
3 | EX-31.2 | tmb-20220630xex31d2.htm | EX-31.2 | 10613
4 | EX-32.1 | tmb-20220630xex32d1.htm | EX-32.1 | 8328
| Complete submission text file | 0001558370-22-012065.txt |  | 8852613

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | tmb-20220630.xsd | EX-101.SCH | 79843
6 | EX-101.CAL | tmb-20220630_cal.xml | EX-101.CAL | 51546
7 | EX-101.DEF | tmb-20220630_def.xml | EX-101.DEF | 364216
8 | EX-101.LAB | tmb-20220630_lab.xml | EX-101.LAB | 560292
9 | EX-101.PRE | tmb-20220630_pre.xml | EX-101.PRE | 514005
80 | EXTRACTED XBRL INSTANCE DOCUMENT | tmb-20220630x10q_htm.xml | XML | 1430399

Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 221134747
SIC: 2834 Pharmaceutical Preparations